Aimed Alliance Joins 19 Advocacy Organizations Opposing Tennessee’s Proposed Closed Formulary

0

On Dec. 24, 2019, Aimed Alliance joined a coalition of advocacy organizations in a letter to the Centers for Medicare & Medicaid Services (CMS), requesting that the agency reject Tennessee’s proposed amendment to the state’s TennCare Demonstration. This amendment proposes to implement a closed formulary in the state’s Medicaid program, which would allow the value of medications to be determined using cost-effectiveness analyses that rely on value assessment metrics like the Quality-Adjusted Life Year (QALY).

This letter calls attention to the fact that the National Council on Disability (NCD) recently concluded that the QALY metric places a lower value on treatments that extend the lives of people with chronic illnesses and disabilities. For this reason, NCD recently cautioned against using the QALY metric to measure the cost-effectiveness of treatments. The letter asserts that allowing a closed formulary that relies on QALY to determine the cost-effectiveness of available treatments will lead to discrimination and reduced access to care.

Read the letter to learn more.

Last Updated on May 15, 2020 by Aimed Alliance

Share.

Comments are closed.